The Cardiovascular Impact of COVID-19


The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the best medical challenge in decades. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe acute respiratory distress syndrome (ARDS), it also affects multiple organs, particularly the circulatory system. Mortality is increased by comorbidities: cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia, cardiac injury, fulminant myocarditis, coronary failure, embolism, and disseminated intravascular coagulation (DIC).



 

  • CDC Recognizes COVID Long-Haulers
  • Cardiac Biomarkers
  • Athlete COVID Long-hauler Cardiac Research
  • Congenital heart diseases
  • Myocardial dysfunction
  • Pediatric Multisystem Inflammatory Syndrome
  • SARS-CoV-2

Related Conference of The Cardiovascular Impact of COVID-19

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

The Cardiovascular Impact of COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in